Breast adenocarcinoma
Item
adenocarcinoma breast cancer
boolean
C0858252 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Peripheral Neuropathy Grade
Item
peripheral neuropathy less than or equal to 1
boolean
C0031117 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
Hormone Therapy Discontinued | Chemoprevention
Item
discontinued hormonal therapy as a chemoprevention while onstudy
boolean
C0279025 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0282515 (UMLS CUI [2])
Left ventricular ejection fraction | Multiple gated acquisition scanning
Item
lvef by muga > 55%?
boolean
C0428772 (UMLS CUI [1])
C0521317 (UMLS CUI [2])
Absolute neutrophil count
Item
absolute neutrophil count (anc)> 1000/µl)
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count > 100,000/µl)
boolean
C0032181 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
sgot or sgpt < 92.5 units/l
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Carcinoma breast stage IV
Item
stage iv breast cancer
boolean
C0278488 (UMLS CUI [1])
Chemotherapy Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma | Immunotherapy Breast Carcinoma | Biotherapy Breast Carcinoma
Item
any chemotherapy, radiation therapy, immunotherapy, or biotherapy for a current breast cancer
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C0005527 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Neoplasms, Second Primary | Skin carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate
Item
active second malignancy, other than adequately treated non-melanoma skin cancers or in situ cervical cancer
boolean
C0085183 (UMLS CUI [1])
C0699893 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0205411 (UMLS CUI [2,3])
C0851140 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0205411 (UMLS CUI [3,3])
Hypersensitivity Doxorubicin | Hypersensitivity Cyclophosphamide | Hypersensitivity Paclitaxel | Hypersensitivity cremophor EL
Item
previous allergy/hypersensitivity to doxorubicin, cyclophosphamide, paclitaxel, or other drugs formulated in cremophor el?
boolean
C0020517 (UMLS CUI [1,1])
C0013089 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0010583 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0144576 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0056476 (UMLS CUI [4,2])
Angina, Unstable | Congestive heart failure | Digitalis Use of | Adrenergic beta-Antagonists | Calcium Blockers | Cardiac Arrhythmia Requirement Therapeutic procedure | Myocardial Infarction
Item
unstable angina, congestive heart failure, current use of digitalis, beta-blockers, or calcium blockers for therapy of congestive heart failure, arrhythmia requiring medical therapy, or a history of a myocardial infarction within 12 months
boolean
C0002965 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0304520 (UMLS CUI [3,1])
C1524063 (UMLS CUI [3,2])
C0001645 (UMLS CUI [4])
C0006684 (UMLS CUI [5])
C0003811 (UMLS CUI [6,1])
C1514873 (UMLS CUI [6,2])
C0087111 (UMLS CUI [6,3])
C0027051 (UMLS CUI [7])
Mental disorders Compliance behavior Limited
Item
psychiatric illness that prevents her from understanding the nature of this study and complying with protocol requirements?
boolean
C0004936 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
Communicable Diseases Resolved
Item
active, unresolved infections
boolean
C0009450 (UMLS CUI [1,1])
C1514893 (UMLS CUI [1,2])
Hypersensitivity Escherichia coli Proteins
Item
sensitivity to e. coli derived proteins
boolean
C0020517 (UMLS CUI [1,1])
C0014834 (UMLS CUI [1,2])
C0033684 (UMLS CUI [1,3])
Anthracycline Antibiotics
Item
prior chemotherapy with an anthracycline
boolean
C0003234 (UMLS CUI [1])
Herceptin
Item
prior herceptin therapy
boolean
C0338204 (UMLS CUI [1])